Earnings Reportpositive

Earnings Report

Other upcoming events for TRVI

Phase 2 ReadoutPhase 2 Readout: haduvio
Phase 2 ReadoutPhase 2 Readout: haduvio
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Nalbuphi

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — TRVI Earnings Report | BioSniper